ライフサイエンスコーパス: microtubule-associated protein 2

1 l damage in all 2-VO rats and slight loss of microtubule associated protein-2.

2 protein kinase Cgamma and phosphorylation of microtubule-associated protein 2.

3 le labeling for the dendrite-specific marker microtubule-associated protein 2.

4 lig2 was coexpressed with a neuronal marker, microtubule-associated protein 2.

5 immunoreactivity for the dendritic protein, microtubule-associated protein 2.

6 against nonphosphorylated neurofilaments and microtubule-associated protein 2.

7 in of Fyn binds to a conserved PXXP motif on microtubule-associated protein-2.

8 of neurites containing the dendritic marker microtubule-associated protein-2.

9 -43 as well as the dendrite-specific marker, microtubule-associated protein-2.

10 as positive for fibronectin and negative for microtubule-associated protein 2 (a neuronal marker) and

11 In the E18 cortex, L1 colocalized with microtubule-associated protein 2, a marker of dendrites

12 o worsened hAPP/Abeta-dependent depletion of microtubule-associated protein 2, a marker of neuronal d

13 otic cytochrome c release and degradation of microtubule-associated protein-2, a marker of neuronal s

14 sociated with differentiated neurons such as microtubule associated protein 2 and neurofilament 200.

15 n of neuronal processes and disappearance of microtubule-associated protein 2 and neurofilament immun

16 tribution of the three neuronal populations: microtubule-associated protein 2 and nonphosphorylated n

17 Relative microtubule-associated protein-2 and calbindin immunorea

18 nd immunoreactivity to neuronal derived Ags (microtubule-associated protein-2 and N-methyl d-aspartat

19 s coexpressed neuronal markers: NeuN, HuC/D, microtubule-associated protein 2, and a dextran placed i

20 the activity-regulated cytoskeletal protein, microtubule-associated protein 2, and alpha-CaM Kinase I

21 calmodulin-dependent kinase II, dendrin, the microtubule-associated protein 2, and neurogranin (RC3)

22 izing-hormone receptor (LHR), inhibin-alpha, microtubule-associated protein 2D, and the PKA type IIbe

23 ecific markers for neuronal nuclear antigen, microtubule-associated protein-2, and calbindin D28k, in

24 t expresses both the neuron-specific marker, microtubule-associated protein-2, and the neurokinin-1 r

25 eflectivity and by immunohistochemistry with microtubule-associated protein 2 antibody.

26 ots, we show that alterations in hippocampal microtubule-associated protein-2 appear to be highly cor

27 ific microtubule-associated proteins tau and microtubule-associated protein-2 are substrates for the

28 s a reflection of total synaptic density and microtubule-associated protein 2 as a dendritic structur

29 splayed multipotency by differentiating into microtubule-associated protein 2, beta-III tubulin, and

30 PR-ir colocalizes with the neuronal marker, microtubule associated protein-2, but not with the glial

31 in reaction (RT-PCR), and levels of KLK8 and microtubule-associated protein 2, c isoform (MAP2c) prot

32 proteins, calbindin, calretinin, synapsin I, microtubule-associated protein-2, calcitonin gene-relate

33 Tau and microtubule-associated protein-2 cysteine oxidation and

34 s identified with calbindin, calretinin, and microtubule-associated protein-2 did not express CB(1) r

35 amount of dendritic simplification based on microtubule-associated protein 2 immunohistochemical sta

36 thod for the determination of the density of microtubule-associated protein 2-immunolabeled neurons i

37 red a widespread network of precocious MAP2 (microtubule-associated protein 2)-immunoreactive cells,

38 d labeling (TUNEL), and decreased numbers of microtubule-associated protein-2-immunoreactive neurons

39 cidic protein immunoreactivity and increased microtubule-associated protein-2 immunoreactivity in the

40 We also previously demonstrated that microtubule-associated-protein-2 immunoreactivity (MAP2-

41 MAP2 (microtubule-associated protein 2) is a cytoskeletal phos

42 d (E)GFP+ cells expressed betaIII-tubulin or microtubule-associated protein-2; many incorporated brom

43 Using an antibody against microtubule associated protein 2 (MAP-2; a specific mark

44 pment at two ages, using an antibody against microtubule associated protein-2 (MAP-2).

45 etal injury with preserved immunolabeling of microtubule-associated protein 2 (MAP 2) at 6 and 24 h a

46 microtubule assembly in vitro stimulated by microtubule-associated protein 2 (MAP 2).

47 duction of significant neurite outgrowth and microtubule-associated protein 2 (MAP-2) and neuron-spec

48 5days in culture), when proteins such as the microtubule-associated protein 2 (MAP-2) and the glutama

49 for 24 h prior to neuron immunostaining with microtubule-associated protein 2 (MAP-2) antibody.

50 Microtubule-associated protein 2 (MAP-2) isoforms are de

51 Microtubule-associated protein 2 (MAP-2), a cellular pro

52 ls of immunostaining for tubulin, actin, and microtubule-associated protein 2 (MAP-2), and levels of

53 describe induction of a juvenile isoform of microtubule-associated protein 2 (MAP-2c) in cultured me

54 as neurons by using neuron-specific markers, microtubule-associated protein-2 (MAP-2) and anti-neuron

55 he neuronal-markers; neuronal nuclei (NeuN), microtubule-associated protein-2 (MAP-2) and betaIII-tub

56 cal microscopy of sections immunolabeled for microtubule-associated protein-2 (MAP-2) and synaptophys

57 s of the CA1 region of the hippocampus using microtubule-associated protein-2 (MAP-2) histochemistry

58 identify degenerating neurons) and decreased microtubule-associated protein-2 (MAP-2) immunoreactivit

59 teins axonal marker tau and dendritic marker microtubule-associated protein-2 (MAP-2).

60 The microtubule associated protein 2 (Map2) helps stabilize

61 response element-binding protein (CREB), and microtubule associated protein 2 (MAP2).

62 e (FITC)-dextran, GFAP immunoreactivity, and microtubule associated protein-2 (MAP2) immunoreactivity

63 Quantitative measures of microtubule associated protein-2 (MAP2) immunostained de

64 ajority of M1 and M2 ipRGCs expressed Isl-1, microtubule associated protein-2 (MAP2), gamma-synuclein

65 localized with neuronal and survival markers microtubule-associated protein 2 (MAP2) and Bcl-2 using

66 4 readily phosphorylates tau and the related microtubule-associated protein 2 (MAP2) and MAP4.

67 Microtubule-associated protein 2 (MAP2) and tau, which i

68 strated that Tat causes rapid degradation of microtubule-associated protein 2 (MAP2) and the collapse

69 -SPION-rIgPxcIgY carries chick polyclonal to microtubule-associated protein 2 (MAP2) as Ran-SPION-rIg

70 uction and mitochondrial damage, and reduced microtubule-associated protein 2 (MAP2) dendrites in hum

71 Isoforms of microtubule-associated protein 2 (MAP2) differ from thei

72 Microtubule-associated protein 2 (MAP2) has been implica

73 Using microtubule-associated protein 2 (MAP2) immunohistochemi

74 Reduction of microtubule-associated protein 2 (MAP2) immunoreactivity

75 -labeling with a monoclonal antibody against microtubule-associated protein 2 (MAP2) in hatchlings sh

76 Microtubule-associated protein 2 (MAP2) is a neuron-spec

77 Microtubule-associated protein 2 (MAP2) is a neuronal ph

78 Microtubule-associated protein 2 (MAP2) is a neuronal pr

79 Microtubule-associated protein 2 (MAP2) is an important

80 indicates that the phosphorylation state of microtubule-associated protein 2 (MAP2) may play a key r

81 Microtubule-associated protein 2 (MAP2), a neuron-specif

82 serves as a marker of dendritic spines, and microtubule-associated protein 2 (MAP2), an overall dend

83 alyze three neuronal markers: synaptophysin, microtubule-associated protein 2 (MAP2), and calbindin.

84 y diminished neuronal damage, as assessed by microtubule-associated protein 2 (MAP2), class III beta-

85 ble immunolabelling for poly(ADP-ribose) and microtubule-associated protein 2 (MAP2), glial fibrillar

86 We hypothesized that proteins such as microtubule-associated protein 2 (MAP2), which can inter

87 tection against severing is also afforded by microtubule-associated protein 2 (MAP2), which has a tau

88 feration (+16%), decreased neurogenesis into microtubule-associated protein 2 (MAP2)-positive neurons

89 uroendocrine tumor markers synaptophysin and microtubule-associated protein 2 (MAP2).

90 ial fibrillary acidic protein (GFAP), and/or microtubule-associated protein 2 (MAP2).

91 to tyrosine hydroxylase (TH), an antibody to microtubule-associated protein 2 (MAP2, a dendritic mark

92 ciated with activity/anxiety behaviours, and microtubule-associated protein 2 (Map2, rs13475902) was

93 alterations in the phosphorylation state of microtubule-associated protein-2 (MAP2).

94 s assessed using (Neuronal Nucleu [NeuN] and microtubule-associated protein 2 [MAP2] + IR).

95 The juvenile isoform of the neuronal microtubule-associated protein 2 (MAP2c) is present in g

96 In this report, we identify AKAP 80 as microtubule-associated protein 2D (MAP2D), a low molecul

97 These alterations in microtubule-associated protein-2 may reflect dendritic r

98 brillary acidic protein (astrocytic marker), microtubule-associated protein 2 (neuronal marker), or 2

99 l cultures derived from two brains generated microtubule-associated protein-2+ neurons, which incorpo

100 enerated cells expressed the neuronal marker microtubule-associated protein-2, or neuron-specific tub

101 e v-abl construct (CA-Abl) show an exuberant microtubule-associated protein 2-positive (MAP2-positive

102 d by a twofold increase in the percentage of microtubule-associated protein 2-positive cells even in

103 nal nuclei-positive neuronal loss and patchy microtubule-associated protein 2-positive dendritic loss

104 ptophysin-positive presynaptic terminals and microtubule-associated protein 2-positive neuronal dendr

105 Oct3/4-positive, undifferentiated status to microtubule-associated protein 2-positive neurons and gl

106 EC24C is disrupted, remained confined to the microtubule-associated protein 2-positive somatodendriti

107 ontrast, Li restored HIVE-associated loss of microtubule-associated protein-2-positive neurites and s

108 tin-positive neuroblasts (-28%), and mature, microtubule-associated protein-2-positive neurons (-36%)

109 ptors were also expressed by postmigrational microtubule-associated protein-2-positive neurons of the

110 onth before training altered the hippocampal microtubule-associated protein-2 response; in these anim

111 tibodies to growth-associated protein-43 and microtubule-associated protein-2 revealed segregation of

112 division, 64 kDa, class III beta-tubulin, or microtubule-associated protein-2 showed that the vast ma

113 synaptotoxicity (decreased synaptophysin and microtubule-associated protein-2 staining) and reactive

114 ncreases in immunohistochemical staining for microtubule-associated protein-2 suggested that there wa

115 This was evidenced by loss of microtubule-associated protein 2, synaptophysin, and neu

116 as well as the endogenous protein substrates microtubule-associated protein 2, tau and spectrin, was

117 igh molecular weight neurofilament proteins, microtubule-associated protein 2, tau, and synaptophysin

118 Cysteine oxidation of tau and microtubule-associated protein-2 to disulfides altered t

119 When immunoreactivity for microtubule-associated protein 2 was assessed in the cor

120 In SIVE, staining for postsynaptic protein microtubule-associated protein-2 was significantly decre

121 f class III neuron-specific beta-tubulin and microtubule-associated protein 2 were significantly incr

122 with reductions in the immunoreactivity for microtubule-associated protein 2, which affects cytoskel

123 Treatment of tau and microtubule-associated protein-2 with either the thiored